Apr-22-20 Initiated
Northland Capital
Outperform
$9
Jan-09-20 Initiated
Piper Sandler
Overweight
$9
Mar-20-19 Initiated
SunTrust
Buy
$7
Jan-31-19 Resumed
Janney
Buy
$5
Jan-26-18 Initiated
Seaport Global Securities
Buy
$5
Aug-14-17 Resumed
Cantor Fitzgerald
Overweight
$4.50
Aug-10-17 Reiterated
H.C. Wainwright
Buy
$4 → $5
May-26-17 Initiated
H.C. Wainwright
Buy
$4
May-17-17 Upgrade
Cantor Fitzgerald
Neutral → Overweight
May-12-16 Reiterated
Piper Jaffray
Overweight
$6 → $4
May-11-16 Downgrade
Cantor Fitzgerald
Buy → Hold
May-04-16 Reiterated
FBR Capital
Outperform
$12 → $9
Mar-14-16 Reiterated
Laidlaw
Buy
$17 → $11
Mar-11-16 Reiterated
FBR Capital
Outperform
$13 → $12
Feb-08-16 Initiated
Piper Jaffray
Overweight
Nov-10-15 Reiterated
FBR Capital
Mkt Perform
$17 → $14
Nov-04-15 Initiated
Cantor Fitzgerald
Buy
May-12-15 Reiterated
Cantor Fitzgerald
Buy
$17 → $12
May-11-15 Reiterated
ROTH Capital
Buy
$16 → $14
Apr-22-15 Resumed
Piper Jaffray
Overweight
Apr-09-21 11:30AM
Mar-30-21 07:22AM
Mar-22-21 01:33AM
Mar-18-21 06:02PM
Mar-10-21 03:30PM
10:12AM
08:31AM
08:00AM
05:30AM
Mar-03-21 12:30PM
Feb-17-21 08:00AM
Feb-11-21 08:00AM
Feb-08-21 10:11AM
Feb-05-21 01:07AM
Jan-15-21 09:00AM
Dec-21-20 11:54PM
Dec-19-20 06:11PM
Dec-05-20 11:31AM
Nov-20-20 08:30AM
Nov-17-20 09:40AM
Nov-11-20 08:30AM
Nov-07-20 08:02AM
Nov-06-20 06:00AM
Nov-05-20 07:00PM
08:00AM
Nov-04-20 05:31PM
05:11PM
Oct-23-20 08:00AM
Sep-28-20 10:41AM
Sep-24-20 10:46AM
08:31AM
Sep-14-20 12:06PM
Sep-11-20 08:00AM
Sep-04-20 11:31AM
Sep-03-20 08:00AM
Aug-10-20 09:08AM
Aug-06-20 10:05AM
Aug-05-20 09:05AM
07:45AM
Jul-29-20 12:33PM
Jul-27-20 04:01PM
Jul-12-20 07:39PM
Jun-10-20 05:44PM
Jun-09-20 11:38PM Thomson Reuters StreetEvents -8.09%
Jun-06-20 11:31AM
May-29-20 12:17PM
May-26-20 10:43AM
May-11-20 08:30AM
May-09-20 05:01PM
May-08-20 10:52AM
May-07-20 06:35PM
04:01PM
Apr-30-20 12:34PM
Apr-28-20 08:00AM
Apr-27-20 12:31PM
Mar-24-20 10:02PM Thomson Reuters StreetEvents +9.32%
Mar-14-20 08:51AM
Mar-13-20 09:29AM
Mar-12-20 08:55PM
04:01PM
02:30PM
Mar-09-20 08:00AM
Mar-05-20 12:30PM
Feb-27-20 05:15PM
Feb-24-20 02:59PM American City Business Journals -5.58%
Feb-20-20 08:00AM
Feb-06-20 10:44AM
Jan-30-20 10:15AM
Jan-29-20 10:06AM
Jan-27-20 05:20PM
10:25AM
Jan-13-20 08:30AM
Jan-08-20 12:00PM
Jan-06-20 08:30AM
Dec-30-19 09:44AM
Dec-27-19 07:53PM
Dec-25-19 12:00PM
Dec-19-19 08:30AM
Dec-12-19 11:30AM
Dec-10-19 10:48AM
Dec-06-19 12:00PM
Dec-05-19 09:07AM
Dec-04-19 11:05AM Thomson Reuters StreetEvents
10:06AM
Dec-03-19 09:16AM
08:57AM
Nov-29-19 09:13AM
Nov-27-19 08:30AM
Nov-25-19 08:30AM
Nov-22-19 09:48AM
Nov-20-19 10:00AM
Nov-19-19 09:26AM
Nov-14-19 10:20AM
Nov-13-19 08:00AM
07:49AM
Nov-12-19 05:25PM
04:01PM
Nov-07-19 08:00AM
Nov-06-19 05:38AM
Nov-05-19 10:31AM
BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products for chronic conditions in the United States and internationally. The company provides its products based on its patented BioErodible MucoAdhesive drug-delivery technology, a small erodible polymer film for application to the buccal mucosa, as well as other drug-delivery technologies. It offers BELBUCA, a buprenorphine buccal film for the treatment of chronic pain; BUNAVAIL, a buprenorphine and naloxone buccal film to treat opioid dependence; and ONSOLIS, a fentanyl buccal soluble film for the management of breakthrough pain in cancer patients. The company also offers Symproic, a peripherally acting mu-opioid receptor antagonist for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent opioid dosage escalation. BioDelivery Sciences International, Inc. was incorporated in 1997 and is headquartered in Raleigh, North Carolina.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Plesha Scott M. See Remarks Mar 12 Option Exercise 0.00 20,834 0 299,874 Mar 16 04:57 PM Bailey Jeffrey Allen Chief Executive Officer Mar 09 Option Exercise 0.00 5,333 0 40,900 Mar 11 04:14 PM Vollins James See Remarks Feb 08 Sale 4.16 3,833 15,945 0 Feb 08 05:46 PM Vollins James See Remarks Feb 04 Sale 3.97 8,303 32,963 3,833 Feb 08 05:46 PM Vollins James See Remarks Feb 01 Option Exercise 0.00 3,833 0 12,136 Feb 02 05:59 PM Smith Thomas B Chief Medical Officer Feb 01 Option Exercise 0.00 7,667 0 19,954 Feb 02 05:55 PM Plesha Scott M. See Remarks Feb 01 Option Exercise 0.00 13,333 0 258,206 Feb 02 06:17 PM Coelho Mary Theresa See Remarks Feb 01 Sale 3.87 3,460 13,390 30,619 Feb 02 07:12 PM Coelho Mary Theresa See Remarks Jan 29 Option Exercise 0.00 10,190 0 34,079 Feb 02 07:12 PM Plesha Scott M. See Remarks Jan 29 Option Exercise 0.00 10,870 0 244,873 Feb 02 06:17 PM Smith Thomas B Chief Medical Officer Jan 29 Option Exercise 0.00 7,548 0 12,287 Feb 02 05:55 PM Vollins James See Remarks Jan 29 Option Exercise 0.00 8,303 0 8,303 Feb 02 05:59 PM Coelho Mary Theresa See Remarks Jan 19 Sale 4.32 6,462 27,916 23,889 Jan 20 04:30 PM Coelho Mary Theresa See Remarks Jan 15 Option Exercise 0.00 18,333 0 30,351 Jan 20 04:30 PM Vollins James See Remarks Dec 16 Option Exercise 3.46 9,505 32,887 9,505 Dec 16 04:39 PM Vollins James See Remarks Dec 16 Sale 4.48 9,505 42,582 0 Dec 16 04:39 PM Bailey Jeffrey Allen Chief Executive Officer Dec 15 Sale 4.35 10,000 43,500 35,567 Dec 16 04:41 PM Vollins James See Remarks Dec 14 Option Exercise 3.46 20,320 70,307 20,320 Dec 16 04:39 PM Vollins James See Remarks Dec 14 Sale 4.46 20,320 90,627 0 Dec 16 04:39 PM Singh Vanila Director Nov 23 Option Exercise 0.00 5,333 0 12,084 Nov 27 04:16 PM Bailey Jeffrey Allen Chief Executive Officer Nov 04 Option Exercise 0.00 40,000 0 45,567 Nov 06 05:21 PM Davis Todd C Director Aug 18 Sale 4.99 50,000 249,500 217,914 Aug 20 04:16 PM Watson W. Mark Director Aug 17 Sale 5.18 13,000 67,340 52,979 Aug 19 04:30 PM Sirgo Mark A Director Aug 14 Sale 4.90 115,000 563,500 1,091,095 Aug 17 06:58 PM Sirgo Mark A Director Aug 13 Sale 4.53 85,000 385,050 1,206,095 Aug 17 06:58 PM KOTLER KEVIN Director Aug 07 Option Exercise 0.98 45,000 43,950 4,355,689 Aug 11 05:16 PM Greenleaf Peter Director Aug 07 Option Exercise 0.00 35,000 0 59,788 Aug 11 05:03 PM Sirgo Mark A Director Aug 07 Option Exercise 0.00 4,000 0 1,291,095 Aug 11 04:55 PM Singh Vanila Director Aug 07 Option Exercise 0.00 6,751 0 6,751 Aug 11 04:54 PM Bailey Jeffrey Allen Chief Executive Officer Aug 07 Option Exercise 0.00 5,567 0 5,567 Aug 11 04:53 PM Watson W. Mark Director Aug 07 Option Exercise 0.00 30,000 0 65,979 Aug 11 04:51 PM Davis Todd C Director Aug 07 Option Exercise 0.00 30,000 0 267,914 Aug 11 04:50 PM Vollins James See Remarks May 21 Option Exercise 3.90 21,666 84,497 21,666 May 22 04:04 PM Vollins James See Remarks May 21 Sale 4.60 21,666 99,664 0 May 22 04:04 PM Plesha Scott M. See Remarks May 18 Sale 4.52 15,000 67,800 234,003 May 20 04:38 PM ODONNELL FRANCIS E JR Director May 11 Option Exercise 0.00 22,500 0 628,038 May 14 04:07 PM Sirgo Mark A Director May 11 Option Exercise 0.00 22,500 0 1,287,095 May 12 06:48 PM Sirgo Mark A Director May 08 Sale 5.07 100,000 507,000 1,264,595 May 12 06:48 PM ODONNELL FRANCIS E JR Director May 06 Sale 4.53 11,250 50,962 605,538 May 08 04:06 PM Cukier Herm Chief Executive Officer May 04 Option Exercise 0.00 66,666 0 102,447 May 05 04:05 PM ODONNELL FRANCIS E JR Director May 04 Sale 4.45 16,000 71,200 616,788 May 05 04:06 PM Sirgo Mark A Director Apr 27 Sale 4.58 100,000 458,000 1,364,595 Apr 29 04:10 PM ODONNELL FRANCIS E JR Director Apr 20 Sale 4.22 20,000 84,400 632,788 Apr 22 04:18 PM Sirgo Mark A Director Apr 15 Sale 4.13 50,000 206,500 1,464,595 Apr 17 04:05 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite